National Action Plan in Antimicrobial Resistance Using Framework Analysis for China
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by Chinese Center for Disease Control and Prevention in China CDC Weekly
- Vol. 5 (22) , 492-498
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populationsThe Lancet Global Health, 2023
- Antibiotic Stewardship in Retail Pharmacies and the Access-Excess Challenge in China: A Policy ReviewAntibiotics, 2022
- The Progress of Global Antimicrobial Resistance Governance and Its Implication to China: A ReviewAntibiotics, 2021
- An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approachThe Lancet Regional Health - Western Pacific, 2021
- Over-the-counter antibiotic sales in community and online pharmacies, ChinaBulletin of the World Health Organization, 2020
- The role of vaccines in fighting antimicrobial resistance (AMR)Human Vaccines & Immunotherapeutics, 2018
- Bioindustry in China: An overview and perspectiveNew Biotechnology, 2018
- Methicillin-resistant Staphylococus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilitiesThe Lancet, 1997